Multinationals Move on Nanotech
Updated from March 28
We all knew this was going to happen.
Nanotechnology has become the neglected stepchild of the markets. The hype and fervor surrounding it a few years ago gave way to warnings that the science would yield precious few applications -- and profit -- for years.
Then came disappointment and then, in the minds of investors at least, oblivion.Aside from some erratic stocks, like Altair Nanotechnologies (ALTI), whose shares are volatile as a result of perennial speculation, and the even-rarer company turning a profit, like electron-microscope maker FEI (FEIC), companies toiling in science on the nanoscale have been quietly treading water. A nanotech exchange-traded fund representing an index of stocks that was set up by Lux Research, a New York-based firm focusing on nanotechnology, has traded sideways. The PowerShares Lux Nanotech ETF (PXN) was recently trading off 0.8% to $17.27. A year ago, it was trading at $18.03. And when the Small Times, a publication devoted to the nanotech industry, appraised the state of 2006 venture investing in the new science, it summed it up this way: "Disappointing ... Just add 'extremely' for public market transactions." The $650 million in venture money invested in nanotech start-ups last year was far below the $1 billion-plus in 2005, and $172 million of that went to three start-ups: NeoPhotonics, Nanosolar and Nanosphere. So dim is the view that public and private investors have taken of the one-time hotbed of innovation that news reports have appeared suggesting that the U.S. might fall behind other emerging economies, especially China.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV